<DOC>
	<DOCNO>NCT01887119</DOCNO>
	<brief_summary>The prevalence obesity obesity-related complication currently take epidemic proportion . These complication increase risk type 2 diabetes cardiovascular disease , important cause morbidity mortality worldwide . It important gain insight mechanism underlie obesity-related complication , may lead development direct therapeutic strategy . Currently , significant evidence cause insulin resistance hypertension must seek level microcirculation . Over activity renin-angiotensin-aldosterone system potential cause microvascular dysfunction . Angiotensin II indeed find implicated pathogenesis obesity-associated hypertension insulin resistance , possibly interference vascular effect insulin . Increased aldosterone level also associate resistant hypertension insulin resistance , illustrate patient primary aldosteronism . Furthermore , aldosterone know exert several detrimental effect vasculature , offset mineralocorticoid receptor antagonist . In obese individual , plasma aldosterone concentration increase well . We hypothesize increased aldosterone level adipose person induce microvascular dysfunction , contribute development insulin resistance hypertension , mineralocorticoid receptor antagonism result improve insulin sensitivity decrease blood pressure counteract adverse effect aldosterone microvasculature .</brief_summary>
	<brief_title>Aldosterone Antagonism Microvascular Function</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Obesity , Abdominal</mesh_term>
	<mesh_term>Eplerenone</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<criteria>Age 4065 year Caucasian Waist circumference &gt; 102 cm ( men ) / &gt; 88 cm ( woman ) Triglycerides &gt; 1.7 mmol/L Highnormal blood pressure ( office blood pressure : 130/85 139/89 mm Hg ) stage I hypertension ( office blood pressure : 140/90 mm Hg 159/99 mm Hg ; 24h ABPM : 125/80 149/89 mm Hg ) Cardiovascular disease ( stroke , coronary artery disease , peripheral vascular disease , congestive heart failure , cardiac shunt , cardiac surgery , pulmonary hypertension , cardiac arrhythmia , family history cardiac arrhythmia sudden cardiac death ) Diabetes mellitus/impaired glucose metabolism ( fast glucose value &gt; 5.6 mmol/L ) Grade 2 3 hypertension ( office blood pressure : &gt; 160/100 mm Hg ; ABPM &gt; 150/90 mm Hg ) Unstable severe pulmonary disease Unstable severe thyroid disorder Inflammatory disease Alcohol use &gt; 2 U/day ( woman ) / &gt; 3 U/day ( men ) Use antihypertensive , lipidlowering glucoselowering medication , Use corticosteroid , medication know inhibit induce CYP3A4 , lithium , tricyclic antidepressant antipsychotic medication , regular use ( weekly several time week ) NSAIDs Plasma potassium level &lt; 3.2 mmol/L &gt; 5 mmol/L eGFR &lt; 60 mL/min Impairment hepatic function Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>